Literature DB >> 3793271

Concordance of histological classification of lung cancer with special reference to adenocarcinoma in Osaka, Japan, and the North-West Region of England.

A Hanai, J S Whittaker, R Tateishi, L H Sobin, R T Benn, C S Muir.   

Abstract

In routinely collected data adenocarcinoma of the lung appeared to be 3 times more frequent in Osaka, Japan, than in the North-Western (NW) Region of England (Manchester). Before embarking on comparative epidemiological studies, it was decided to investigate the comparability of histological diagnosis. Specimens from 60 NW Region lung cancer patients and 52 Osaka patients were exchanged and reviewed. The entire material was then independently assessed by the WHO Collaborating Centre for Histological Classification of Tumours. The interpretation of the WHO Classification (WHO, 1981) by the NW Region and by Osaka was upheld by the WHO Collaborating Centre in 89% and 93% of all cases and in 97% and 100% of adenocarcinoma cases respectively. Agreement between the 2 centres was 88% for the main cell types. Differences in the frequency of adenocarcinoma of lung between the NW Region and Osaka are thus not due to diagnostic artefact and require further exploration. The aetiological implications of the finding that many Chinese and Japanese women with lung adenocarcinoma do not smoke (77% in Osaka) are discussed.

Entities:  

Mesh:

Year:  1987        PMID: 3793271     DOI: 10.1002/ijc.2910390103

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets.

Authors:  Juneko E Grilley-Olson; D Neil Hayes; Dominic T Moore; Kevin O Leslie; Matthew D Wilkerson; Bahjat F Qaqish; Michele C Hayward; Christopher R Cabanski; Xiaoying Yin; Mark A Socinski; Thomas E Stinchcombe; Leigh B Thorne; Timothy Craig Allen; Peter M Banks; Mary B Beasley; Alain C Borczuk; Philip T Cagle; Rebecca Christensen; Thomas V Colby; Georgean G Deblois; Göran Elmberger; Paolo Graziano; Craig F Hart; Kirk D Jones; Diane M Maia; C Ryan Miller; Keith V Nance; William D Travis; William K Funkhouser
Journal:  Arch Pathol Lab Med       Date:  2012-05-14       Impact factor: 5.534

2.  Trends of lung cancer incidence by histologic type: a population-based study in Osaka, Japan.

Authors:  T Sobue; W Ajiki; H Tsukuma; A Oshima; A Hanai; I Fujimoto
Journal:  Jpn J Cancer Res       Date:  1999-01

3.  Reproducibility of diagnosis and its influence on the distribution of lung cancer by histologic type in Osaka, Japan.

Authors:  S Yamamoto; T Sobue; N Yamaguchi; S Yamamoto; M Kikui; Y Kusunoki; A Oshima; A Hanai
Journal:  Jpn J Cancer Res       Date:  2000-01

4.  Comparison of lung cancer incidence rates by histological type in high and low incidence countries, with reference to the limited role of smoking.

Authors:  A Hanai; T Benn; I Fujimoto; C S Muir
Journal:  Jpn J Cancer Res       Date:  1988-04

5.  Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker.

Authors:  Jaileene Pérez-Morales; Darielys Mejías-Morales; Stephanie Rivera-Rivera; Jonathan González-Flores; Mónica González-Loperena; Fernando Y Cordero-Báez; Wilfredo M Pedreira-García; Camille Chardón-Colón; Jennifer Cabán-Rivera; W Douglas Cress; Edna R Gordian; Teresita Muñoz-Antonia; Mauricio Cabrera-Ríos; Angel Isidro; Domenico Coppola; Marilin Rosa; Theresa A Boyle; Victoria Izumi; John M Koomen; Pedro G Santiago-Cardona
Journal:  PLoS One       Date:  2018-11-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.